Position Summary
The Associate Director for IO Lung Cancer in Global Medical Oncology develops and implements Global/US Medical strategies and objectives in lung cancer (non-metastatic), related to nivolumab and ipilimumab. The role aligns tumor strategies through cross-functional relationships with US Commercialization, Global Medical, Clinical Development, and Medical Capabilities.
Key Responsibilities
- Collaborate with the Medical Product Lead to develop/implement the GMO medical plan (product differentiation, lifecycle management, and disease-specific strategies aligned with Commercialization and R&D).
- Provide strategic/scientific/executional leadership with the integrated matrix team (Medical Communications, Evidence Generation, Commercial, Field Medical, R&D, GPT, Access).
- Develop and implement medical activities: medical advisory boards, Scientific Engagement Partner resources/training, congresses, reactive content, communication strategy, and publications.
- Implement data generation strategies and oversee Investigator-Sponsored Research (ISR) programs (concept to execution), including evidence reporting in congresses and peer-reviewed publications and proactive/reactive communication tools.
- Plan and deliver medical objectives with flawless execution and budget utilization.
- Partner with Discovery, Clinical Research, Regulatory, and Health Outcomes to ensure pipeline/marketed product science is understood and communicated internally/externally.
- Build long-term relationships with external Thought Leaders to assess unmet needs and develop medical strategies.
- Ensure alignment of medical strategies/objectives/tactics across the medical matrix and integration with the strategic brand plan.
Qualifications & Experience
- Advanced scientific degree (PharmD, MD, PhD).
- 5+ years pharmaceutical industry experience in medical affairs (preferred).
- Strong organization and ability to lead multiple projects across matrix teams.
- Excellent verbal and written communication/presentation skills.
- Understanding of pharmaceutical drug development, including clinical development, regulatory, life cycle management, and Thought Leader collaboration.
- Clinical expertise and/or relevant disease-area experience in thoracic cancers (Medical Affairs/Clinical Development).
- Strong interpersonal skills to navigate complex situations and align stakeholders.
- Demonstrated results delivery in deadline-driven environments.
- Estimated 25% travel (as applicable).